Intranasal steroids have traditionally been reserved for patients with severe allergic symptoms not controlled by antihistamines alone. Recently, the use of these agents as a first-line therapy has become more common, especially after the release of newer formulations requiring only once or twice daily dosing. In a recent consensus paper, the American College of Allergy, Asthma, and Immunology listed intranasal steroids as the most effective therapy in controlling the symptoms of allergic rhinitis. There are currently six corticosteroids available in an intranasal dosage form: beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate, mometasone furoate, and triamcinolone acetate.[2,3,4,5,6]
Pediatr Pharm. 2001;7(5) © 2001 Children's Medical Center, University of Virginia
Cite this: Intranasal Steroids for Children With Allergic Rhinitis - Medscape - May 01, 2001.